A 73-year-old male with CLCNEC of the lung containing adenocarcinoma and sarcomatoid components was treated with chemotherapy consisting of carboplatin and nanoparticle albumin-bound (nab)-paclitaxel plus atezolizumab, which was decided in accordance with the histological evaluation of the components. Here, ALB is linked to adenocarcinoma.